The US Food and Drug Administration (FDA) has published draft guidance aimed at improving the performance of pulse oximeters across all skin colours, following research suggesting the medical devices ...

Medically reviewed by Elizabeth Barnes, RDN Optimizing cognitive health is top of mind for many adults, and there are many ...

In its last few days of power, the Biden administration is expected to officially propose a limit on nicotine in cigarettes.

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

More than 1,300 pounds of cat food are being recalled due to Salmonella contamination, according to a notice from the U.S.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.

Mersana on Friday said the new designation covers the drug, XMT-1660, for the treatment of advanced or metastatic breast cancer in patients with human epidermal growth factor receptor 2 low or ...

Acquisition to expand cardiovascular portfolio with complementary and differentiated calcium modification platform, ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...